Literature DB >> 11510810

Variations in the prevalence across countries of chronic bronchitis and smoking habits in young adults.

I Cerveri1, S Accordini, G Verlato, A Corsico, M C Zoia, L Casali, P Burney, R de Marco.   

Abstract

The present work aims to assess the international variation in the prevalence of chronic bronchitis and its main risk factor, smoking habits, in young adults of 35 centres from 16 countries. Respiratory symptoms and pulmonary function were assessed in 17,966 subjects (20-44 yrs), randomly selected from the general population, in the frame of the European Community Respiratory Health Survey. The median prevalence of chronic bronchitis was 2.6%, with wide variations across countries (p<0.001; 0.7-9.7%). The prevalence of current smokers ranged 20.1-56.9%, (p<0.001) with a median value of 40%. Current smoking was the major risk factor for chronic bronchitis, especially in males. Its effect increased according to number of pack-yrs: in males, the odds ratio of chronic bronchitis was 3.51 (95% confidence interval (CI) 2.31-5.32) in 1-14 pack-yrs smokers and increased to 17.32 (9.97-30.11) in > or = 45 pack-yrs smokers with respect to nonsmokers. Only 30% of the geographical variability in prevalence could be explained by differences in smoking habits, suggesting that other environmental and/or genetic factors may play an important role. In conclusion, chronic bronchitis is a substantial health problem even in young adults. The impressive prevalence in current smokers in most countries highlights the need to improve the quality of prevention.

Entities:  

Mesh:

Year:  2001        PMID: 11510810     DOI: 10.1183/09031936.01.00087101

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  42 in total

1.  The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers.

Authors:  Jorge Luiz Carrão; Leila Beltrami Moreira; Flávio Danni Fuchs
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2007-10       Impact factor: 5.270

2.  Chronic Bronchitis: Where Are We Now?

Authors:  Yaniv Dotan; Jennifer Y So; Victor Kim
Journal:  Chronic Obstr Pulm Dis       Date:  2019-04-09

3.  Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis.

Authors:  C Fuhrman; E Jougla; J Nicolau; D Eilstein; M-C Delmas
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

Review 4.  Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema.

Authors:  Barbara A Forey; Alison J Thornton; Peter N Lee
Journal:  BMC Pulm Med       Date:  2011-06-14       Impact factor: 3.317

5.  Determining factors in the prescription of moxifloxacin in exacerbations of chronic bronchitis in the primary-care setting.

Authors:  Marc Miravitlles; Carles Llor
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

6.  The clinical impact of non-obstructive chronic bronchitis in current and former smokers.

Authors:  Carlos H Martinez; Victor Kim; Yahong Chen; Ella A Kazerooni; Susan Murray; Gerard J Criner; Jeffrey L Curtis; Elizabeth A Regan; Emily Wan; Craig P Hersh; Edwin K Silverman; James D Crapo; Fernando J Martinez; Meilan K Han
Journal:  Respir Med       Date:  2013-11-15       Impact factor: 3.415

7.  The determinants of chronic bronchitis in Aboriginal children and youth.

Authors:  Alomgir Hossain; Stephanie Konrad; James A Dosman; Ambikaipakan Senthilselvan; Jesse McCrosky; Punam Pahwa
Journal:  Can Respir J       Date:  2012 Nov-Dec       Impact factor: 2.409

8.  Chronic bronchitis among nonsmoking farm women in the agricultural health study.

Authors:  Martin Valcin; Paul K Henneberger; Greg J Kullman; David M Umbach; Stephanie J London; Michael C R Alavanja; Dale P Sandler; Jane A Hoppin
Journal:  J Occup Environ Med       Date:  2007-05       Impact factor: 2.162

Review 9.  Chronic bronchitis and chronic obstructive pulmonary disease.

Authors:  Victor Kim; Gerard J Criner
Journal:  Am J Respir Crit Care Med       Date:  2012-11-29       Impact factor: 21.405

10.  An international survey of chronic obstructive pulmonary disease in young adults according to GOLD stages.

Authors:  R de Marco; S Accordini; I Cerveri; A Corsico; J Sunyer; F Neukirch; N Künzli; B Leynaert; C Janson; T Gislason; P Vermeire; C Svanes; J M Anto; P Burney
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.